Stifel Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $105

Benzinga Newsdesk www.benzinga.com Neutral 54.3%

Neg 0% Neu 54.3% Pos 0%

Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $110 to $105.